EcoDrugPlus

24-Dehydrocholesterol Reductase

Ensembl ID : ENSCVAG00000015558
Gene Symbol: DHCR24
3 Cross references
209 Possible Orthologues:

26s Proteasome Non-Atpase Regulatory Subunit 11b

Ensembl ID : ENSCVAG00000005990
Gene Symbol: LOC107093226
3 Cross references
215 Possible Orthologues:

26s Proteasome Non-Atpase Regulatory Subunit 4

Ensembl ID : ENSCVAG00000018823
Gene Symbol: LOC107101111
3 Cross references
228 Possible Orthologues:

26s Proteasome Non-Atpase Regulatory Subunit 4-Like

Ensembl ID : ENSCVAG00000001915
Gene Symbol: LOC107096288
3 Cross references
221 Possible Orthologues:

26s Proteasome Non-Atpase Regulatory Subunit 6-Like

Ensembl ID : ENSCVAG00000000450
Gene Symbol: LOC107104171
4 Cross references
212 Possible Orthologues:

3-Hydroxy-3-Methylglutaryl-Coa Reductase

Ensembl ID : ENSCVAG00000000631
Gene Symbol: HMGCR
3 Cross references
194 Possible Orthologues:

3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase-Like

Ensembl ID : ENSCVAG00000013227
Gene Symbol: LOC107090374
3 Cross references
206 Possible Orthologues:

3-Oxo-5-Alpha-Steroid 4-Dehydrogenase 2-Like

Ensembl ID : ENSCVAG00000008517
Gene Symbol: LOC107104491
3 Cross references
208 Possible Orthologues:

3-Phosphoinositide Dependent Protein Kinase 1

Ensembl ID : ENSCVAG00000022460
Gene Symbol: PDPK1
3 Cross references
222 Possible Orthologues:

4-Hydroxyphenylpyruvate Dioxygenase-Like

Ensembl ID : ENSCVAG00000000139
Gene Symbol: LOC107092762
3 Cross references
207 Possible Orthologues:

40s Ribosomal Protein S19

Ensembl ID : ENSCVAG00000016949
Gene Symbol: LOC107084670
3 Cross references
321 Possible Orthologues:

40s Ribosomal Protein S5-Like

Ensembl ID : ENSCVAG00000008716
Gene Symbol: LOC107081314
3 Cross references
250 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).